Ubiquitin immunostaining and inclusion body myositis: Study of 30 patients with inclusion body myositisRichard A Prayson; Mark L Cohen · 1997

Sporadic Inclusion Body Myositis and Hereditary Inclusion Body MyopathySimmons, Zachary; Towfighi, Javad · Journal of Clinical Neuromuscular Disease · 2002

An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three familiesSivakumar, K · Brain · 1997

Inclusion body myositis: A chronic persistent mumps myositis?Samuel M. Chou · 1986

Sporadic Inclusion-Body Myositis and Hereditary Inclusion-Body MyopathiesAskanas, Valerie; Engel, W. King · Archives of Neurology · 1998

Sporadic inclusion body myositis misdiagnosed as granulomatous myositisMozaffar, T.; Lavian, M.; Goyal, N. · Neuromuscular Disorders · 2015

Sporadic inclusion body myositis misdiagnosed as idiopathic granulomatous myositisLavian, Monica; Goyal, Namita; Mozaffar, Tahseen · Neuromuscular Disorders · 2016

HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathiesBoyd M Koffman; Kumaraswamy Sivakumar; Toni Simonis; David Stroncek; Marinos C Dalakas · 1998

Targeting protein homeostasis in sporadic inclusion body myositisAhmed, M.; Machado, P. M.; Miller, A.; Spicer, C.; Herbelin, L.; He, J.; Noel, J.; Wang, Y.; McVey, A. L.; Pasnoor, M.; Gallagher, P.; Statland, J.; Lu, C.-H.; Kalmar, B.; Brady, S.; Sethi, H.; Samandouras, G.; Parton, M.; Holton, J. L.; Weston, A.; Collinson, L.; Taylor, J. P.; Schiavo, G.; Hanna, M. G.; Barohn, R. J.; Dimachkie, M. M.; Greensmith, L. · Science Translational Medicine · 2016

Activity in People With Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a Two-Site Randomized Controlled TrialKluding, P. M.; Singleton, J. R.; Pasnoor, M.; Dimachkie, M. M.; Barohn, R. J.; Smith, A. G.; Marcus, R. L. · Physical Therapy · 2016

P71 A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM)P. Machado; A. Miller; M. Parton; L. Dewar; J.L. Holton; M. Dimachkie; L. Herbelin; L. Greensmith; R. Barohn; M.G. Hanna · 2011

LB0002 Safety and Tolerability of Arimoclomol in Patients with Sporadic Inclusion Body Myositis: A Randomised, Double-Blind, Placebo-Controlled, Phase IIa Proof-of-Concept TrialMachado, P.; Miller, A.; Herbelin, L.; He, J.; Noel, J.; Wang, Y.; McVey, A. L.; Pasnoor, M.; Gallagher, P.; Statland, J.; Brady, S.; Lu, C.- H.; Kalmar, B.; Sethi, H.; Samandouras, G.; Holton, J.; Greensmith, L.; Barohn, R. J.; Hanna, M. G.; Dimachkie, M. M. · Annals of the Rheumatic Diseases · 2013